BetterLife Pharma Inc. (OTCMKTS:BETRF) Short Interest Down 33.8% in March

BetterLife Pharma Inc. (OTCMKTS:BETRF) was the recipient of a significant drop in short interest during the month of March. As of March 31st, there was short interest totalling 9,600 shares, a drop of 33.8% from the March 15th total of 14,500 shares. Based on an average daily volume of 12,200 shares, the short-interest ratio is currently 0.8 days. Approximately 0.0% of the company’s stock are sold short.

BetterLife Pharma Price Performance

Shares of OTCMKTS BETRF opened at $0.06 on Friday. BetterLife Pharma has a one year low of $0.05 and a one year high of $0.15. The business’s 50-day moving average price is $0.07 and its two-hundred day moving average price is $0.08. The company has a market capitalization of $8.29 million, a P/E ratio of -2.13 and a beta of 1.47.

BetterLife Pharma Company Profile

BetterLife Pharma Inc, a biotechnology company, engages in the development and commercialization of compounds for the treatment of mental disorders in Canada. It is also involved in refining and developing drug candidates from a set of complementary interferon-based technologies that have the potential to engage the immune system to fight virus infections.